Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection

Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection

Patients with colonic adenocarcinoma (COAD) are at relatively high risk of SARS-CoV-2 infection. However, there is a lack of medical strategies to treat COVID-19/COAD comorbidity. Puerarin, a natural product, is a known antiviral, antitumor, and immunomodulatory effect. Therefore, we hypothesised th...

Full description

Bibliographic Details
Main Authors: Weizheng Liang, Xiushen Li, Yue Yao, Qingxue Meng, Xueliang Wu, Hao Wang, Jun Xue
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
puerarin
COVID-19
COAD
comorbidity
network pharmacology
bioinformatics
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.921517/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.921517/full

Similar Items